MAPT and Cognitive impairment: The activation of GSK3β has been shown to promote Aβ production and aggregation, leading to excessive Tau protein phosphorylation and subsequent neurofibrillary tangle formation [41], ultimately resulting in neuronal damage and cognitive deficits [42].